Literature DB >> 23984961

Measles elimination: progress, challenges and implications for rubella control.

Felicity T Cutts1, Justin Lessler, Charlotte J E Metcalf.   

Abstract

Measles and rubella are major vaccine-preventable causes of child mortality and disability. They have been eliminated from the Americas and some other regions have also come close to elimination. In this paper, we review regional progress toward measles and rubella control/elimination goals, describe the recent epidemiology of these infections and discuss challenges to achieving the goals. Globally, measles vaccination is estimated to prevent nearly 2 million deaths each year. Despite this remarkable progress, large measles outbreaks have occurred in recent years, often involving older persons who were not vaccinated in earlier years. Such an occurrence would be particularly damaging for rubella control programmes as it could lead to peaks in congenital rubella syndrome. Challenges to achieving and sustaining high vaccination coverage include civil conflict, weak health systems, geographic, cultural and economic barriers to reaching certain population groups and inadequate monitoring and use of data for action. Countries and regions aiming to eliminate measles and control rubella urgently need to improve the implementation and monitoring of both routine and mass vaccination campaign strategies.

Entities:  

Mesh:

Year:  2013        PMID: 23984961     DOI: 10.1586/14760584.2013.814847

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  24 in total

Review 1.  Seasonal Population Movements and the Surveillance and Control of Infectious Diseases.

Authors:  Caroline O Buckee; Andrew J Tatem; C Jessica E Metcalf
Journal:  Trends Parasitol       Date:  2016-11-16

2.  Persistence of rubella and mumps antibodies, following changes in the recommended age for the second dose of MMR vaccine in Portugal.

Authors:  G Gonçalves; J Frade; M S J Nascimento; J R Mesquita; C Nunes
Journal:  Epidemiol Infect       Date:  2016-08-04       Impact factor: 4.434

3.  Transport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa.

Authors:  C J E Metcalf; A Tatem; O N Bjornstad; J Lessler; K O'Reilly; S Takahashi; F Cutts; B T Grenfell
Journal:  Epidemiol Infect       Date:  2014-08-14       Impact factor: 4.434

Review 4.  Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus.

Authors:  Renata da Fontoura Budaszewski; Veronika von Messling
Journal:  Viruses       Date:  2016-10-11       Impact factor: 5.048

5.  Global Transmission Dynamics of Measles in the Measles Elimination Era.

Authors:  Yuki Furuse; Hitoshi Oshitani
Journal:  Viruses       Date:  2017-04-16       Impact factor: 5.048

6.  Elimination of measles from India: Challenges ahead and the way forward.

Authors:  S B Bavdekar; S Karande
Journal:  J Postgrad Med       Date:  2017 Apr-Jun       Impact factor: 1.476

7.  Timeliness and completeness of measles vaccination among children in rural areas of Guangxi, China: A stratified three-stage cluster survey.

Authors:  Xianyan Tang; Alan Geater; Edward McNeil; Hongxia Zhou; Qiuyun Deng; Aihu Dong
Journal:  J Epidemiol       Date:  2017-02-08       Impact factor: 3.211

8.  Rubella antibodies in cord blood sera in Portugal: association with maternal age and vaccination status.

Authors:  J Frade; C Nunes; J R Mesquita; M São José Nascimento; G Gonçalves
Journal:  Epidemiol Infect       Date:  2018-02-20       Impact factor: 4.434

9.  Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.

Authors:  Amy Wesolowski; Keitly Mensah; Cara E Brook; Miora Andrianjafimasy; Amy Winter; Caroline O Buckee; Richter Razafindratsimandresy; Andrew J Tatem; Jean-Michel Heraud; C Jessica E Metcalf
Journal:  J R Soc Interface       Date:  2016-04       Impact factor: 4.118

Review 10.  Monitoring vaccination coverage: Defining the role of surveys.

Authors:  Felicity T Cutts; Pierre Claquin; M Carolina Danovaro-Holliday; Dale A Rhoda
Journal:  Vaccine       Date:  2016-06-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.